
Optimi Health fell 64.6% from $6.08 to $2.15, behind the S&P 500's −0.2%. Its worst day was Jun 5 (−17.7%), and its low came Nov 3 at $2.11.
May 20, 2026 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.36 was reported on $72,549.00 revenue.
+3.7% · S&P 500 +0.1%
Optimi Health shares fell 15.6%, while the S&P 500 fell 0.3%.
−15.6% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
Optimi Health shares rose 14.4%, while the S&P 500 rose 0.8%.
+14.4% · S&P 500 +0.8%
Optimi Health shares rose 15.3%, while the S&P 500 rose 0.4%.
+15.3%, the year's best day · S&P 500 +0.4%
EPS of $-0.40 missed the $-0.26 estimate on $101,275.00 revenue (est. $130,000.00).
−0.8% · S&P 500 −0.5%
Optimi Health closed at its lowest level of the year, 65.3% below where the year started.
−6.2% · S&P 500 +0.3%
Where it ended: a close of $2.15 on Nov 16, 2026. Up next: Q4 2026 earnings on Dec 8, 2026 (EPS est. $-0.29, revenue est. $160,000.00).
Nothing in the past 12 months.
All OPTH analyst actionsNothing in the past 12 months.
All OPTH dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OPTH and SPY from Benzinga historical bars. Not investment advice.